{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:27:56Z","timestamp":1790868476062,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2003,2,25]],"date-time":"2003-02-25T00:00:00Z","timestamp":1046131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00439-003-0908-6","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:23:12Z","timestamp":1576102992000},"page":"542-551","source":"Crossref","is-referenced-by-count":34,"title":["Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics"],"prefix":"10.1007","volume":"112","author":[{"given":"Clare L.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly-Anne","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,2,25]]},"reference":[{"key":"0908_CR1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian BCSG","year":"2000","unstructured":"Anglian BCSG (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases, Anglian Breast Cancer Study. Br J Cancer 83:1301\u20131308","journal-title":"Br J Cancer"},{"key":"0908_CR2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/94.16.1221","volume":"94","author":"Begg","year":"2002","unstructured":"Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221\u20131226","journal-title":"J Natl Cancer Inst"},{"key":"0908_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/94.3.205","volume":"94","author":"Chenevix-Trench","year":"2002","unstructured":"Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, Dork T, Bendix R, Kirk J, Tucker K, McCredie MR, Hopper JL, Sambrook J, Mann GJ, Khanna KK (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94:205\u2013215","journal-title":"J Natl Cancer Inst"},{"key":"0908_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004390100505","volume":"109","author":"den","year":"2001","unstructured":"den Dunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121\u2013124","journal-title":"Hum Genet"},{"key":"0908_CR5","first-page":"678","volume":"52","author":"Easton","year":"1993","unstructured":"Easton DF, Bishop DT, Ford D, Crockford GP (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52:678\u2013701","journal-title":"Am J Hum Genet"},{"key":"0908_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajmg.1320560305","volume":"56","author":"Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265\u2013271","journal-title":"Am J Hum Genet"},{"key":"0908_CR7","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1038\/sj.onc.1205033","volume":"20","author":"Fan","year":"2001","unstructured":"Fan S, Yuan R, Ma YX, Meng Q, Goldberg ID, Rosen EM (2001) Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 20:8215\u20138235","journal-title":"Oncogene"},{"key":"0908_CR8","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1126\/science.280.5371.1831","volume":"280","author":"Finkel","year":"1998","unstructured":"Finkel E (1998) Australia takes two-step approach on genetic studies. Science 280:1831\u20131832","journal-title":"Science"},{"key":"0908_CR9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692\u2013695","journal-title":"Lancet"},{"key":"0908_CR10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"0908_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1294-399","volume":"8","author":"Friedman","year":"1994","unstructured":"Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399\u2013404","journal-title":"Nat Genet"},{"key":"0908_CR12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng1295-428","volume":"11","author":"Gayther","year":"1995","unstructured":"Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, et al. (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428\u2013433","journal-title":"Nat Genet"},{"key":"0908_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","volume":"15","author":"Gayther","year":"1997","unstructured":"Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BA, Stratton MR, Easton D (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15:103\u2013105","journal-title":"Nat Genet"},{"key":"0908_CR14","unstructured":"Giles G, Farrugia H, Silver B, Staples M (1992) Cancer in Victoria 1982\u20131987. Victorian Cancer Registry, Melbourne, p103"},{"key":"0908_CR15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/81691","volume":"26","author":"Healey","year":"2000","unstructured":"Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA (2000) A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26:362\u2013364","journal-title":"Nat Genet"},{"key":"0908_CR16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ng0396-298","volume":"12","author":"Holt","year":"1996","unstructured":"Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA (1996) Growth retardation and tumour inhibition by BRCA1. Nat Genet 12:298\u2013302","journal-title":"Nat Genet"},{"key":"0908_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/scbi.2001.0392","volume":"11","author":"Hopper","year":"2001","unstructured":"Hopper JL (2001) Genetic epidemiology of female breast cancer. Semin Cancer Biol 11:367\u2013374","journal-title":"Semin Cancer Biol"},{"key":"0908_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/oxfordjournals.jncimonographs.a024232","volume":"26","author":"Hopper","year":"1999","unstructured":"Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, McCredie MR, Giles GG (1999a) Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 26:95\u2013100","journal-title":"J Natl Cancer Inst Monogr"},{"key":"0908_CR19","first-page":"741","volume":"8","author":"Hopper","year":"1999","unstructured":"Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ (1999b) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 8:741\u2013747","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"0908_CR20","unstructured":"Lange K, Boehnke M, Weeks D (1987) Programs for pedigree analysis. University of California at Los Angeles, Los Alamos"},{"key":"0908_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng1196-253","volume":"14","author":"Mazoyer","year":"1996","unstructured":"Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gayther SA, Mangion J, Stratton MR, Lynch HT, Goldgar DE, Ponder BA, Lenoir GM (1996) A polymorphic stop codon in BRCA2. Nat Genet 14:253\u2013254","journal-title":"Nat Genet"},{"key":"0908_CR22","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.2000.18.11.2250","volume":"18","author":"Meiser","year":"2000","unstructured":"Meiser B, Butow P, Friedlander M, Schnieden V, Gattas M, Kirk J, Suthers G, Haan E, Tucker K (2000) Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18:2250\u20132257","journal-title":"J Clin Oncol"},{"key":"0908_CR23","first-page":"254","volume":"56","author":"Narod","year":"1995","unstructured":"Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BA, Weber BL, Garber JE, Birch JM (1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 56:254\u2013264","journal-title":"Am J Hum Genet"},{"key":"0908_CR24","unstructured":"NBCC (2000) Advice about familial aspects of breast cancer and ovarian cancer. A guide for health professionals. National Breast Cancer Centre, Australia"},{"key":"0908_CR25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5694\/j.1326-5377.2000.tb124064.x","volume":"172","author":"Osborne","year":"2000","unstructured":"Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF (2000) kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med J Aust 172:463\u2013464","journal-title":"Med J Aust"},{"key":"0908_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2307\/2530008","volume":"34","author":"Patil","year":"1978","unstructured":"Patil GP, Rao CR (1978) Weighted distributions and size biased sampling with application to wildlife populations and human families. Biometrics 34:179\u2013189","journal-title":"Biometrics"},{"key":"0908_CR27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00439-001-0615-0","volume":"109","author":"Povey","year":"2001","unstructured":"Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678\u2013680","journal-title":"Hum Genet"},{"key":"0908_CR28","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616\u20131622","journal-title":"N Engl J Med"},{"key":"0908_CR29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700\u2013710","journal-title":"Am J Hum Genet"},{"key":"0908_CR30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.1995.03520310033026","volume":"273","author":"Shattuck-Eidens","year":"1995","unstructured":"Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, et al. (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273:535\u2013541","journal-title":"JAMA"},{"key":"0908_CR31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.bjc.6690008","volume":"79","author":"Southey","year":"1999","unstructured":"Southey MC, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MR, Hopper JL, Venter DJ (1999) BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer 79:34\u201339","journal-title":"Br J Cancer"},{"key":"0908_CR32","first-page":"413","volume":"11","author":"Spurdle","year":"2002","unstructured":"Spurdle A, Hopper J, Chen X, Dite G, Cui J, McCredie M, Giles G, Ellis-Steinborner S, Venter D, Newman B, Southey M, Chenevix-Trench G (2002) The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev 11:413\u2013416","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"0908_CR33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"Thompson","year":"2001","unstructured":"Thompson D, Easton D (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68:410\u2013419","journal-title":"Am J Hum Genet"},{"key":"0908_CR34","first-page":"329","volume":"11","author":"Thompson","year":"2002","unstructured":"Thompson D, Easton D (2002) Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 11:329\u2013336","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"0908_CR35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/hmg\/10.7.705","volume":"10","author":"Welcsh","year":"2001","unstructured":"Welcsh PL, King MC (2001) BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10:705\u2013713","journal-title":"Hum Mol Genet"},{"key":"0908_CR36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng1296-430","volume":"14","author":"Wu","year":"1996","unstructured":"Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14:430\u2013440","journal-title":"Nat Genet"},{"key":"0908_CR37","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1038\/sj.onc.1203968","volume":"19","author":"Zheng","year":"2000","unstructured":"Zheng L, Li S, Boyer TG, Lee WH (2000) Lessons learned from BRCA1 and BRCA2. Oncogene 19:6159\u20136175","journal-title":"Oncogene"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-003-0908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-003-0908-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-003-0908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:23:25Z","timestamp":1576103005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-003-0908-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,25]]},"references-count":37,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0908"],"URL":"https:\/\/doi.org\/10.1007\/s00439-003-0908-6","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,25]]}}}